Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trade
San Francisco, California, United Statestradebio.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Trade Biosciences is a biotechnology company focused on the discovery and development of novel small molecule therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes its proprietary Trade Platform to identify and optimize drug candidates for a variety of indications, including metabolic diseases, inflammation, and neurological disorders. By leveraging advanced computational and experimental techniques, Trade Biosciences aims to address unmet medical needs through the modulation of GPCR signaling pathways. The company's pipeline is currently in the pre-clinical stage, with several programs undergoing lead optimization and validation.
- Therapeutic areas
- ImmunologyNeurologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Trade.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trade.